Healthcare & Pharmaceutical Market Intelligence
Nigeria is the commercial engine of West Africa's pharmaceutical industry, combining massive demand, strong local manufacturing, large-scale imports, and the region's most advanced fertility healthcare ecosystem.
233M+
Population (2024)
USD 959M
Pharma Imports (2024)
≈60–70%
Imported Medicines
≈USD 3.0–3.2B
Pharma Market (2025)
12–17%
Female Infertility Burden
≈60–70% Imported • ≈30–40% Local Manufacturing
Key Market Indicators
≈USD 3.0–3.2B
Formal Pharmaceutical Market (2025)
USD 1.84B
Dietary Supplements (7.29% CAGR 2026–2034)
USD 120–220M
Fertility Care Market
≈30–40%
Local Manufacturing
USD 959M Imports • USD 1.67M Exports • 574:1
Most Advanced Fertility Ecosystem in West Africa
6–18%
PCOS prevalence (population-based ~6%, higher in fertility clinics)
18.1%
PCOS among women presenting to infertility clinics (Enugu • Southeast Nigeria)
12–17%
Female infertility burden
40–50%
Female factor contribution of infertility cases
40–60%
Male factor contribution of infertility cases
Sources: Trade Data OEC (HS30) 2024 • Nigeria NBS • IQVIA • WHO • World Bank • UN Comtrade • Industry reports • Major contributors: PID / infections, hormonal disorders, ovulatory dysfunction, lifestyle, oxidative stress, delayed access, environmental exposures
Medical & Commercial Drivers
Increasing fertility awareness and delayed childbearing
Expansion of private IVF centers
Rising demand for Assisted Reproductive Technologies (ART)
Predominantly private-pay healthcare
Strong demand for fertility-support nutraceuticals
Largest pharmaceutical market in West Africa
Strongest pharmaceutical manufacturing ecosystem in West Africa
Largest pharmaceutical import demand: USD 959M (2024)
Largest nutraceutical market in West Africa: USD 1.84B
Most advanced fertility treatment ecosystem in West Africa
